Shanghai Conant Optical Co. Ltd. Class H (HK:2276)
:2276
Want to see HK:2276 full AI Analyst Report?
Top Page
Shanghai Conant Optical Co. Ltd. Class H
(2276)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$41.00
▼(-24.21% Downside)
Action:Downgraded
Date:05/03/26
The score is primarily supported by strong financial performance (expanding margins and materially reduced leverage), tempered by mixed cash conversion and a 2025 revenue decline. Technicals are a notable drag due to a weak trend (price below key moving averages and negative MACD). Valuation is neutral-to-slightly supportive with a ~20x P/E but a low dividend yield.
Positive Factors
Margin expansion
Sustained gross and net margin expansion indicates durable pricing power and operating leverage. Higher margins improve resilience to revenue volatility, support stronger operating cash flow potential, and create headroom to invest in R&D, distribution, or selectively defend market share over the medium term.
Negative Factors
2025 revenue decline
A recent revenue decline interrupts prior top-line momentum and may reflect end-market softness or normalization after strong growth. Persisting or recurring revenue weakness would pressure capacity utilization, slow scale benefits, and could make margin gains harder to sustain over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Margin expansion
Sustained gross and net margin expansion indicates durable pricing power and operating leverage. Higher margins improve resilience to revenue volatility, support stronger operating cash flow potential, and create headroom to invest in R&D, distribution, or selectively defend market share over the medium term.
Read all positive factors
Shanghai Conant Optical Co. Ltd. Class H (2276) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$18.68B
Dividend Yield0.63%
Average Volume (3M)2.08M
Price to Earnings (P/E)26.9
Beta (1Y)0.36
Revenue Growth6.10%
EPS Growth16.45%
CountryHK
Employees2,723
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)1.20
Shares Outstanding498,269,800
10 Day Avg. Volume1,581,306
30 Day Avg. Volume2,077,117
Financial Highlights & Ratios
PEG Ratio2.29
Price to Book (P/B)8.22
Price to Sales (P/S)10.31
P/FCF Ratio93.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$58.86Price Target Upside8.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.63
Revenue Forecast (FY)HK$2.96B
Shanghai Conant Optical Co. Ltd. Class H Business Overview & Revenue Model
Company Description
Shanghai Conant Optical Co., Ltd. specializes in the global production and sale of resin eyeglass lenses. The company's extensive reach covers continents such as Asia, Europe, North and South America, Africa, and Oceania, in addition to its home m...
How the Company Makes Money
null...
Shanghai Conant Optical Co. Ltd. Class H Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
86
Very Positive
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.19B | 2.06B | 1.76B | 1.56B | 1.36B |
| Gross Profit | 917.46M | 795.10M | 658.13M | 537.87M | 460.16M |
| EBITDA | 682.24M | 582.02M | 465.77M | 354.97M | 296.89M |
| Net Income | 557.72M | 428.28M | 327.02M | 248.57M | 183.52M |
Balance Sheet | |||||
| Total Assets | 3.55B | 2.39B | 1.98B | 1.79B | 1.81B |
| Cash, Cash Equivalents and Short-Term Investments | 1.48B | 648.52M | 551.52M | 452.14M | 735.34M |
| Total Debt | 299.14M | 317.54M | 214.95M | 355.08M | 599.23M |
| Total Liabilities | 802.11M | 803.23M | 589.41M | 643.02M | 873.95M |
| Stockholders Equity | 2.74B | 1.59B | 1.39B | 1.15B | 937.40M |
Cash Flow | |||||
| Free Cash Flow | 241.90M | 252.62M | 348.50M | 65.59M | 20.52M |
| Operating Cash Flow | 536.63M | 477.81M | 480.68M | 185.12M | 58.28M |
| Investing Cash Flow | -957.90M | -152.13M | -273.24M | -158.76M | 140.44M |
| Financing Cash Flow | 556.59M | -157.07M | -212.35M | -281.00M | 189.27M |
Shanghai Conant Optical Co. Ltd. Class H Technical Analysis
Negative
54.10
Price Trends
44.39
Negative
51.28
Negative
49.43
Negative
Market Momentum
-2.09
Positive
29.81
Positive
19.15
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2276, the sentiment is Negative. The current price of 54.1 is above the 20-day moving average (MA) of 41.10, above the 50-day MA of 44.39, and above the 200-day MA of 49.43, indicating a bearish trend. The MACD of -2.09 indicates Positive momentum. The RSI at 29.81 is Positive, neither overbought nor oversold. The STOCH value of 19.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2276.
Shanghai Conant Optical Co. Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
37.48
3.42
10.03%
HK:0907
Elegance Optical International Holdings Limited
0.06
-0.04
-36.46%
Shanghai Conant Optical Co. Ltd. Class H Corporate Events
Shanghai Conant Optical Completes HK$398 Million H Share Buyback and Cancels Shares
Jun 15, 2026
Shanghai Conant Optical has completed its April 2026 H share repurchase programme, which had an approved cap of HK$400 million, by buying back a total of 8,655,200 H shares on the Hong Kong Stock Exchange for about HK$397.99 million. The initiativ...
Shanghai Conant Optical Sets Final 2025 Dividend and Details Tax Treatment for H-Shareholders
Jun 11, 2026
Shanghai Conant Optical Co., Ltd. has declared a final ordinary dividend of RMB 0.2 per share for the financial year ended 31 December 2025, which was approved by shareholders on 11 June 2026. For H-share investors in Hong Kong, the dividend will ...
Shanghai Conant Optical Shareholders Overwhelmingly Approve 2025 Reports at AGM
Jun 11, 2026
Shanghai Conant Optical Co., Ltd., a PRC-based optical lens manufacturer listed in Hong Kong, held its annual general meeting on 11 June 2026 with more than half of its eligible share capital represented. The meeting was convened in accordance wit...
Shanghai Conant Optical Shareholders Approve Amendments to Articles at First 2026 EGM
Jun 11, 2026
Shanghai Conant Optical Co., Ltd. reported the poll results of its first extraordinary general meeting of 2026, held in Shanghai on 11 June, where a quorum representing about 54.21% of voting shares was present. Shareholders approved a special res...
Shanghai Conant Optical Calls June 2026 EGM to Amend Articles of Association
May 26, 2026
Shanghai Conant Optical Co., Ltd., a Hong Kong-listed optical company incorporated in the PRC, has convened its first extraordinary general meeting of 2026 for shareholders. The firm, overseen by a diversified board of executive, non‑executi...
Shanghai Conant Optical Moves to Update Articles for New Listing and PRC Company Law Rules
May 21, 2026
Shanghai Conant Optical Co., Ltd. plans to amend its articles of association to align with recent changes to Hong Kong listing rules, including measures to expand the paperless listing regime and prepare for the implementation of an uncertificated...
Shanghai Conant Optical Cancels HK$129.7 Million in Repurchased H Shares
May 10, 2026
Shanghai Conant Optical Co., Ltd., a PRC-based optical lens manufacturer listed in Hong Kong, operates through a group structure in the ophthalmic and optical products market. The company supplies lenses and related optical products to eyewear and...
Shanghai Conant Optical Updates AGM Auditor Details and Final Dividend Book Closure
Apr 30, 2026
Shanghai Conant Optical Co., Ltd. has issued an update ahead of its 11 June 2026 annual general meeting, where shareholders will consider a proposed final dividend of RMB0.20 per share for the 2025 financial year. The company confirmed that an ord...
Shanghai Conant Optical Calls 2026 AGM, Proposes Dividend and Share Issuance Mandate
Apr 28, 2026
Shanghai Conant Optical Co., Ltd. has called its annual general meeting for 11 June 2026 in Shanghai, where shareholders will review and vote on the company’s 2025 annual report, board and supervisory committee reports, consolidated financia...
Shanghai Conant Named Core Lens Supplier in Major Smart Glasses Deal
Apr 22, 2026
Shanghai Conant Optical Co., Ltd. announced a major breakthrough in smart glasses optics, having signed a binding multi-year mass production memorandum of understanding with a leading global technology company in the smart glasses sector. The agre...
Shanghai Conant Optical Unveils HK$400 Million H-Share Buyback Plan for 2026
Apr 7, 2026
Shanghai Conant Optical Co., Ltd. has approved a 2026 H-share repurchase plan under an existing and a proposed new repurchase mandate, signaling confidence in its future prospects and valuation. The initiative aims to protect shareholder interests...
Shanghai Conant Optical Delivers Strong 2025 Profit Growth and Higher Dividend
Mar 31, 2026
Shanghai Conant Optical Co., Ltd., a major Chinese optical lens producer, reported another year of growth as it continued to expand sales volumes across its key markets. The company leverages large-scale manufacturing of lens products to support r...
Shanghai Conant Optical Announces Final Dividend for 2025 Financial Year
Mar 31, 2026
Shanghai Conant Optical Co., Ltd., a Hong Kong-listed optical manufacturer specializing in lenses and related eyewear components, continues to position itself as a key player in the regional optical market through its equity listing under stock co...
Shanghai Conant Invests RMB180 Million in AR Unicorn Lingban to Deepen Smart Glasses Push
Mar 29, 2026
Shanghai Conant Optical Co., Ltd. has invested RMB 180 million from internal resources to acquire up to a 5% stake in Lingban Technology (Hangzhou) Co., Ltd., a Chinese unicorn in human-computer interaction and AR whose Rokid brand holds a strong ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.